EULAR Corporate members
EULAR is set up of four types of institutional members: scientific societies, national organisations of people with arthritis/rheumatism and health professionals as well as corporate members.
Biogen International GmbH
Boehringer Ingelheim Pharma GmbH & Co. KG
Bristol-Myers Squibb UPSA
Celltrion Healthcare Co. Ltd.
Fresenius Kabi SwissBioSim
Hoffmann-La Roche Ltd.
IBSA Institut Biochimique SA
Novartis Pharma AG
Pfizer Pharmaceutical Group
TRB Chemedica International SA
UCB PHARMA SA
Vifor Fresenius Medical Care Renal Pharma Ltd.
The EULAR Family
A presentation of the EULAR member organisations.
EULAR is governed by an elected board composed by 4 experts in rheumatology and one representative of each pillar (organisations representing other health professionals in rheumatology, patient organisations and scientific societies). Our activities are overseen by 5 content committees and 4 representation committees whose activities are delivered by several hundred expert rheumatology volunteers.
EULAR underscores the importance of combating rheumatic diseases not only by medical means, but also through a wider context of care for rheumatic patients and a thorough understanding of their social and other needs.
EULAR comprises the HPR, PARE and EMEUNET communities, which include 105 member societies / organisations, working on a variety of activities supporting EULAR objectives.